Chapter 5 Organic illness

• Presentations of organic illness 126
  
• Dementia: general overview 128
  
• Alzheimer’s disease 1 130
  
• Alzheimer’s disease 2 132
  
• Alzheimer’s disease 3: pharmacological treatments 134
  
• Dementia with Lewy bodies (DLB) 136
  
• Fronto-temporal dementia (FTD) (Pick’s disease) 138
  
• Vascular dementia 140
  
• Prion diseases 142
  
• Amnestic disorders 144
  
• Normal pressure hydrocephalus (NPH) 146
  
• Chronic subdural haematoma (SDH) 147
  
• Psychiatric sequelae of CVA 148
  
• Psychiatric aspects of head injury 150
  
• Psychiatric aspects of epilepsy 1 152
  
• Psychiatric aspects of epilepsy 2 154
  
• HIV/AIDS and psychiatry 1 156
  
• HIV/AIDS and psychiatry 2: clinical presentations 158
  
• Neuropsychiatric aspects of CNS infections 160
  
• Autoimmune disorders and psychiatry 162
  
• Movement disorders in psychiatry 163
  
• Parkinson’s disease (PD) and psychiatry 164
  
• Huntington’s disease (HD) 166
  
• Wilson’s disease (WD) 167
  
• Other movement disorders 168
  

1 Burns A and Forstl H (1998) Alzheimer disease. In R Butler and B Pitt, eds, Seminars in old age psychiatry, Gaskell, London.

1 Scarpini E, Scheltens P and Feldman H (2003) Treatment of Alzheimer’s disease: current status and new perspectives. Lancet (Neurology), 2, 539–47.

1 Weiner M (1999) Dementia associated with Lewy bodies: dilemmas and directions. Archives of Neurology, 56, 1441.[Full Text]

2 Holmes C, Cairns N, Lantos P and Mann A (1999) Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psych, 174, 45–50.[Abstract/Full Text]

3 Gómez-Tortosa E, Newell K, Irizarry MC et al. (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology, 53, 1284–91.[Abstract/Full Text]

4 McKeith I, Del Ser T, Spano P et al. (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356, 2031–6.[CrossRef][Web of Science][Medline]

5 McKeith IG, Galasko D, Kosaka K et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–24.[Abstract/Full Text]

1 Neary D, Snowden JS, Gustafson L et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 51, 1546–54.[Abstract/Full Text]

2 Snowden JS, Neary D and Mann DM (2002) Frontotemporal dementia. BJP, 180, 140–3.

1 Rossor M and Brown J (1998) Vascular and other dementias In R Butler and B Pitt, eds, Seminars in old age psychiatry, London, Gaskell.

2 Gelder M, Gath D, Mayou R and Cowen P (1996) Oxford Textbook of Psychiatry, 3rd edn, Oxford, Oxford University Press.

1 Lishman WA (1997) Organic psychiatry. Oxford, Blackwell Science.

1 Rao V and Lyketsos C (2000) Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics, 41, 95–103.[CrossRef][Medline]

1 Sachdev P (1998) Schizophrenia-like psychosis and epilepsy: the status of the association. AJP, 155, 325–36.

2 Lishman WA (1997) Organic psychiatry. Oxford, Blackwell Science.

* Recent examination of archived brain material from the epidemic has failed to demonstrate influenza RNA. It is now thought to be autoimmune mediated—see Dale RC, Church AJ, Surtees RA, et al. (2004) Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases? Brain, 127, 21–33.[Abstract/Full Text]